Annual CFF
$125.00 K
-$132.01 M-99.91%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual cash flow from financing activities is $125.00 thousand, with the most recent change of -$132.01 million (-99.91%) on December 31, 2022.
- During the last 3 years, TCRR annual CFF has fallen by -$79.40 million (-99.84%).
Performance
TCRR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$24.00 K
-$17.00 K-41.46%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly cash flow from financing activities is $24.00 thousand, with the most recent change of -$17.00 thousand (-41.46%) on March 31, 2023.
- Over the past year, TCRR quarterly CFF has dropped by -$35.00 thousand (-59.32%).
Performance
TCRR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$90.00 K
-$35.00 K-28.00%
March 31, 2023
Summary
- As of February 9, 2025, TCRR TTM cash flow from financing activities is $90.00 thousand, with the most recent change of -$35.00 thousand (-28.00%) on March 31, 2023.
- Over the past year, TCRR TTM CFF has dropped by -$565.00 thousand (-86.26%).
Performance
TCRR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TCRR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.9% | -59.3% | -86.3% |
| 3 y3 years | -99.8% | -52.0% | +542.9% |
| 5 y5 years | -99.2% | -100.0% | -99.9% |
TCRR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -81.7% | -295.8% | -99.9% | at low |
| 5 y | 5-year | -99.9% | at low | -100.0% | -295.8% | -100.0% | -84.4% |
| alltime | all time | -99.9% | at low | -100.0% | -5583.3% | -100.0% | -84.4% |
TCR2 Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $24.00 K(-41.5%) | $90.00 K(-28.0%) |
| Dec 2022 | $125.00 K(-99.9%) | $41.00 K(-43.1%) | $125.00 K(-41.9%) |
| Sep 2022 | - | $72.00 K(-253.2%) | $215.00 K(-55.8%) |
| Jun 2022 | - | -$47.00 K(-179.7%) | $486.00 K(-25.8%) |
| Mar 2022 | - | $59.00 K(-55.0%) | $655.00 K(-99.5%) |
| Dec 2021 | $132.14 M(-1.9%) | $131.00 K(-61.8%) | $132.14 M(-0.2%) |
| Sep 2021 | - | $343.00 K(+181.1%) | $132.39 M(-50.3%) |
| Jun 2021 | - | $122.00 K(-99.9%) | $266.28 M(+0.0%) |
| Mar 2021 | - | $131.54 M(>+9900.0%) | $266.19 M(+97.6%) |
| Dec 2020 | $134.70 M | $387.00 K(-99.7%) | $134.70 M(+0.2%) |
| Sep 2020 | - | $134.23 M(>+9900.0%) | $134.41 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $29.00 K(-42.0%) | $418.00 K(+2885.7%) |
| Mar 2020 | - | $50.00 K(-51.5%) | $14.00 K(-100.0%) |
| Dec 2019 | $79.52 M(-35.3%) | $103.00 K(-56.4%) | $79.52 M(+1.8%) |
| Sep 2019 | - | $236.00 K(-162.9%) | $78.10 M(+1.3%) |
| Jun 2019 | - | -$375.00 K(-100.5%) | $77.11 M(-6.5%) |
| Mar 2019 | - | $79.56 M(-6145.5%) | $82.43 M(-32.9%) |
| Dec 2018 | $122.94 M(+660.6%) | -$1.32 M(+74.1%) | $122.94 M(-1.1%) |
| Sep 2018 | - | -$756.00 K(-115.3%) | $124.26 M(-0.6%) |
| Jun 2018 | - | $4.95 M(-95.9%) | $125.01 M(+4.1%) |
| Mar 2018 | - | $120.07 M | $120.07 M |
| Dec 2017 | $16.16 M(-28.1%) | - | - |
| Dec 2016 | $22.49 M | - | - |
FAQ
- What is TCR2 Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual CFF year-on-year change?
- What is TCR2 Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly CFF year-on-year change?
- What is TCR2 Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for TCR2 Therapeutics?
- What is TCR2 Therapeutics TTM CFF year-on-year change?
What is TCR2 Therapeutics annual cash flow from financing activities?
The current annual CFF of TCRR is $125.00 K
What is the all time high annual CFF for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual cash flow from financing activities is $134.70 M
What is TCR2 Therapeutics annual CFF year-on-year change?
Over the past year, TCRR annual cash flow from financing activities has changed by -$132.01 M (-99.91%)
What is TCR2 Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TCRR is $24.00 K
What is the all time high quarterly CFF for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly cash flow from financing activities is $134.23 M
What is TCR2 Therapeutics quarterly CFF year-on-year change?
Over the past year, TCRR quarterly cash flow from financing activities has changed by -$35.00 K (-59.32%)
What is TCR2 Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TCRR is $90.00 K
What is the all time high TTM CFF for TCR2 Therapeutics?
TCR2 Therapeutics all-time high TTM cash flow from financing activities is $266.28 M
What is TCR2 Therapeutics TTM CFF year-on-year change?
Over the past year, TCRR TTM cash flow from financing activities has changed by -$565.00 K (-86.26%)